Influence of transplantation regimen on prognostic significance of high-level minimal residual disease before allogeneic stem cell transplantation in children with ALL

Bone Marrow Transplantation

Volumn 28, Issue 11, 2001, Pages 1087-1089

  Schneider, M ^a   Hettinger, K ^a   Matthes Martin, S ^a   Konrad, M ^a   Peters, C ^a   Gadner, H ^a   Panzer Grumayer E R ^a  

^a ST ANNA CHILDREN S HOSPITAL   (Austria)

Author keywords

Bone marrow transplantation; Childhood ALL; Minimal residual disease

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ETOPOSIDE; METHOTREXATE; PREDNISONE; THYMOCYTE ANTIBODY;

ACUTE LYMPHOBLASTIC LEUKEMIA; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CASE REPORT; CHILD; DONOR; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; LEUKEMIA REMISSION; LYMPHOCYTE DEPLETION; MALE; MINIMAL RESIDUAL DISEASE; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; T LYMPHOCYTE; WHOLE BODY RADIATION;

CHILD; CHILD, PRESCHOOL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA, B-CELL, ACUTE; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, PRE-B-CELL; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; PROGNOSIS; REMISSION INDUCTION; RETROSPECTIVE STUDIES; RISK FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0035668440     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1703286     Document Type: Article

References (10)

1. Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood
2. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukaemia
3. Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia
4. Minimal residual disease status before allogeneic bone marrow transplantation is an important determinant of successful outcome for children and adolescents with acute lymphoblastic leukaemia
5. Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995
6. Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets: Report of concerted action: Investigation of minimal residual disease in acute leukemia
7. Monitoring antithymocyte globulin (ATG) in bone marrow recipients
8. Impact of T cell depletion on outcome of allogeneic bone-marrow transplantation for standard risk leukaemias
9. Pediatric marrow transplantation for acute leukaemia using unrelated donors and T-replete or -deplete grafts: A case-matched analysis
10. The significance of graft-versus-host disease and pretransplantation minimal residual disease status to outcome after allogeneic stem cell transplantation in patients with acute lymphoblastic leukemia